ATF Updates Gun Purchase Form to Reflect Medical Marijuana’s New Federal Status

The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) has proposed a significant change to the federal gun purchase process, acknowledging the recently updated federal status of medical marijuana. The revised Form 4473, released for public comment on Friday, marks the first time the agency has distinguished between medical and recreational cannabis use in its screening questions for gun buyers. This update comes in the wake of the Trump administration’s move to reschedule marijuana products regulated under state medical programs to Schedule III of the Controlled Substances Act, changing their legal landscape at the federal level

Historically, Form 4473 required gun purchasers to confirm they were not unlawful users of marijuana or other controlled substances, with a warning that cannabis remained illegal nationwide regardless of state law. The new language on the form now specifies, “Federal law does not permit the use or possession of marijuana for recreational purposes,” notably omitting prior references to medical marijuana. This reflects recent federal policy shifts and may reduce confusion for patients legally registered under state medical cannabis programs

The change follows Acting Attorney General Todd Blanche’s order last month, which immediately moved state-regulated medical marijuana to Schedule III and extended similar status to FDA-approved cannabis products. According to a Congressional Research Service report, this rescheduling now provides certain protections for patients who possess medical marijuana from state-licensed dispensaries. The report notes, “The order appears to authorize end users to possess marijuana for medical use without a CSA-compliant prescription.”

ATF is currently accepting public comments on the revised form through July 7, inviting stakeholders and the public to weigh in on the proposed changes. Meanwhile, the Trump administration is considering whether to continue defending the federal law (922(g)(3)) that criminalizes gun possession by cannabis users. At a recent press briefing, Blanche stated, “Every case is different this is something that we’re looking carefully at case by case to make sure that we are doing the right thing—consistent with the Constitution, consistent with the Second Amendment, consistent with this administration’s priorities.”

Despite these updates, federal policy remains complex. In March, the administration argued before the U.S. Supreme Court that the law barring cannabis consumers from gun ownership is constitutional, and the Solicitor General has maintained that marijuana’s rescheduling should not affect pending court decisions. Separately, ATF is also reviewing its definition of “unlawful user of or addicted to any controlled substance,” with a related interim rule open for comment until June 30, which could further impact the rights of cannabis users under federal firearms regulations

From the OG Lab perspective, these regulatory adjustments signal a pivotal shift in how federal authorities view medical cannabis users’ rights, particularly concerning firearms ownership. As agencies solicit public input and the courts weigh in, the cannabis industry and its patients should watch closely for further developments that could reshape both access to medical marijuana and the intersection of gun rights and cannabis use in the months ahead